ZYGLIP
Tablet, 145mg
RxActive license
Active substance (INN)
fenofibrate
Pharmaceutical form
Pharmaceutical formTablet
Strength145mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerAlkaloid AD Skopje, North Macedonia
Therapeutic groupCardiovascular system (C10AB05)
Marketing authorization holderDRUŠTVO "ALKALOID" D.O.O. PODGORICA
Authorization dateDecember 24, 2024
Analogs in Montenegro
3Other medicines with the same active substance
Source: CInMED register